Back to FEDERATED HERMES, INC. FEDERATED HERMES, INC.

RARERARE
29 quarters

Position history for FEDERATED HERMES, INC.FEDERATED HERMES, INC.'s holdings in ULTRAGENYX PHARMACEUTICAL IN

No. Federated Hermes exited its RARE (Ultragenyx Pharmaceutical in) position in Q4 2025. Its Q3 2025 13F listed 496,060 shares worth $14.9M. Federated Hermes already held RARE in its Q4 2018 13F, the earliest on record, and held it in 28 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$55.5M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$23.00
0
2025-Q3
Decreased
496,060
-75.8%
$14.9M0.0%$30.08
0
2025-Q2
Decreased
2M
-0.3%
$74.5M0.1%$36.36
0
2025-Q1
Increased
2.1M
+0.3%
$74.4M0.2%$36.21
35
2024-Q4
Decreased
2M
-2.9%
$86.2M0.2%$42.07
0
2024-Q3
Increased
2.1M
+0.2%
$117.2M0.3%$55.55
36
2024-Q2
Increased
2.1M
+8.7%
$86.6M0.2%$41.10
39
2024-Q1
Decreased
1.9M
-20.8%
$90.5M0.2%$46.69
0
2023-Q4
Increased
2.4M
+11.4%
$117M0.3%$47.82
40
2023-Q3
Increased
2.2M
+23.6%
$78.3M0.2%$35.65
43
2023-Q2
Decreased
1.8M
-29.7%
$82M0.2%$46.13
0
2023-Q1
Decreased
2.5M
-18.4%
$101.3M0.3%$40.10
0
2022-Q4
Decreased
3.1M
-18.9%
$143.4M0.4%$46.33
0
2022-Q3
Increased
3.8M
+0.5%
$158M0.5%$41.41
36
2022-Q2
Decreased
3.8M
-4.8%
$226.5M0.6%$59.66
0
2022-Q1
Increased
4M
+0.0%
$289.6M0.7%$72.62
43
2021-Q4
Decreased
4M
0.0%
$335.3M0.6%$84.09
0
2021-Q3
Increased
4M
+3.5%
$359.6M0.7%$90.19
45
2021-Q2
Decreased
3.9M
-1.6%
$367.2M0.7%$95.35
0
2021-Q1
Decreased
3.9M
-8.6%
$445.5M0.9%$113.86
0
2020-Q4
Increased
4.3M
+4.5%
$592.6M1.2%$138.43
52
2020-Q3
Increased
4.1M
+0.3%
$336.5M0.8%$82.19
44
2020-Q2
Increased
4.1M
+1.6%
$319.2M0.8%$78.22
44
2020-Q1
Increased
4M
+35.1%
$178.5M0.5%$44.43
56
2019-Q4
Increased
3M
+4.1%
$126.9M0.3%$42.71
38
2019-Q3
Increased
2.9M
+60.8%
$122.1M0.3%$42.78
52
2019-Q2
Increased
1.8M
+1.4%
$112.7M0.3%$63.50
36
2019-Q1
Increased
1.7M
+37.0%
$121.3M0.3%$69.36
47
2018-Q4
First report
1.3M
-
$55.5M0.2%$43.48
0

Other major holders of RARE: PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used